Haleon plc (NYSE:HLN) Shares Bought by Brown Advisory Inc.

Brown Advisory Inc. grew its stake in Haleon plc (NYSE:HLN) by 14.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,427 shares of the company’s stock after buying an additional 5,104 shares during the period. Brown Advisory Inc.’s holdings in Haleon were worth $341,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Hexagon Capital Partners LLC lifted its position in Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after acquiring an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. lifted its holdings in shares of Haleon by 853.4% in the 4th quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after purchasing an additional 4,267 shares during the last quarter. SRS Capital Advisors Inc. lifted its holdings in shares of Haleon by 456.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock valued at $45,000 after purchasing an additional 4,477 shares during the last quarter. NBC Securities Inc. acquired a new stake in shares of Haleon in the 3rd quarter valued at about $82,000. Finally, Hoxton Planning & Management LLC purchased a new position in Haleon during the 4th quarter worth approximately $85,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of HLN opened at $8.38 on Monday. The company has a market capitalization of $38.26 billion, a PE ratio of 27.93, a P/E/G ratio of 2.22 and a beta of 0.28. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.96. The company has a 50-day simple moving average of $8.32 and a 200-day simple moving average of $8.32. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last issued its earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The company had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. Equities research analysts predict that Haleon plc will post 0.46 earnings per share for the current fiscal year.

Haleon Announces Dividend

The business also recently announced a semi-annual dividend, which was paid on Thursday, May 16th. Shareholders of record on Friday, March 15th were given a dividend of $0.1064 per share. The ex-dividend date of this dividend was Thursday, March 14th. This represents a yield of 1.8%. Haleon’s payout ratio is currently 70.00%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HLN shares. HSBC began coverage on Haleon in a report on Wednesday, April 17th. They issued a “buy” rating on the stock. Argus restated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.